Tianli Cheng

机构：Central South University, Hunan Cancer Hospital

发表论文 31 篇 · 总被引 838 次 · h-index 15

代表论文

• Menstrual blood-derived stem cells: toward therapeutic mechanisms, novel strategies, and future perspectives in the treatment of diseases (2019 · Stem Cell Research & Therapy · 被引 167)
• Tumor organoids: synergistic applications, current challenges, and future prospects in cancer therapy (2021 · 癌症：英文版 · 被引 159)
• The progress and challenge of anti-PD-1/PD-L1 immunotherapy in treating non-small cell lung cancer (2021 · Therapeutic Advances in Medical Oncology · 被引 76)
• miR ‐21‐5p/ SMAD7 axis promotes the progress of lung cancer (2021 · Thoracic Cancer · 被引 60)
• Pretreatment neutrophil-to-lymphocyte ratio is associated with immunotherapy efficacy in patients with advanced cancer: a systematic review and meta-analysis (2025 · Scientific Reports · 被引 47)
• Identification of the key genes and characterizations of Tumor Immune Microenvironment in Lung Adenocarcinoma (LUAD) and Lung Squamous Cell Carcinoma (LUSC) (2020 · Journal of Cancer · 被引 47)